Morepen Laboratories Limited — Others, 12-05-2025: Monitoring Agency Report

Morepen Laboratories Limited has announced a Monitoring Agency Report on the utilization of Rs. 200 crore raised via QIP. Rs. 49.41 crore has been spent on modernizing and expanding manufacturing units at Baddi and Masulkhana, with some delays due to ongoing infrastructure work; the remaining planned capex will be spent by FY26. Working capital allocation increased slightly to Rs. 66.29 crore, of which Rs. 64.65 crore is utilized. Unused funds of Rs. 75.02 crore remain invested in debt mutual funds and bank accounts, generating returns, with no changes to the deployment plan.